Cargando…
Case report: Pallidal deep brain stimulation for treatment of tardive dystonia/dyskinesia secondary to chronic metoclopramide medication
OBJECTIVES: Tardive dystonia/dyskinesia (TDD) occurs as a side effect of anti-dopaminergic drugs, including metoclopramide, and is often refractory to medication. While pallidal deep brain stimulation (DBS) has become an accepted treatment for TDD secondary to neuroleptic medication, there is much l...
Autores principales: | Nagel, Johanna M., Ghika, Joseph, Runge, Joachim, Wolf, Marc E., Krauss, Joachim K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9877408/ https://www.ncbi.nlm.nih.gov/pubmed/36712453 http://dx.doi.org/10.3389/fneur.2022.1076713 |
Ejemplares similares
-
METOCLOPRAMIDE IN TARDIVE DYSKINESIA
por: Hemanani, T.J., et al.
Publicado: (1983) -
Pallidal Deep Brain Stimulation for Monogenic Dystonia: The Effect of Gene on Outcome
por: Tisch, Stephen, et al.
Publicado: (2021) -
Development of Hyperkinesias after Long-term Pallidal Stimulation for Idiopathic Segmental Dystonia
por: Wloch, Andreas, et al.
Publicado: (2017) -
Long-Term Follow-Up of 12 Patients Treated with Bilateral Pallidal Stimulation for Tardive Dystonia
por: Koyama, Hiroshi, et al.
Publicado: (2021) -
Long-term effects of pallidal deep brain stimulation in tardive dystonia: a follow-up of 5–14 years
por: Krause, Patricia, et al.
Publicado: (2022)